Over the last decade, novel technologies have allowed scientists to devise strategies to give the immune system the upper hand against cancer. Our latest STAT Report will give you a thorough background in the science of the exciting new approaches that researchers are using to help the immune system regain the upper hand on cancer. It focuses on five cancer targets that are the subject of active research that have recently shown promise in clinical or preclinical research. They are: - LAG-3,
- TGF-beta,
- CLDN-6,
- Mesothelin,
- and KRAS.
We’ll outline the biology of these targets, as well as the strategies that researchers are using to attack them. If they prove safe and effective, these new treatments would provide clinicians with more tools to treat cancer, even as it wriggles out from under the thumb of the things doctors try. Get the report
About STAT Reports STAT Reports help business executives, researchers, consultants, and analysts navigate the ever-changing life sciences industry. Each report provides deep analysis of a particular issue in health care. Pick and purchase the reports that are most relevant to you. Learn More
Other topics include: | 
No comments